Suppr超能文献

接受胃癌内镜黏膜切除术的患者根除幽门螺杆菌后胃蛋白酶原I/II比值的长期随访

Long-term follow-up of pepsinogen I/II ratio after eradication of Helicobacter pylori in patients who underwent endoscopic mucosal resection for gastric cancer.

作者信息

Nam Su Youn, Jeon Seong Woo, Lee Hyun Seok, Kwon Yong Hwan, Park Haeyoon, Choi Jin Woo

机构信息

Kyungpook National University Medical Center, Kyungpook National University School of Medicine, Daegu, South Korea.

Kyungpook National University Medical Center, Kyungpook National University School of Medicine, Daegu, South Korea.

出版信息

Dig Liver Dis. 2017 May;49(5):500-506. doi: 10.1016/j.dld.2016.12.016. Epub 2016 Dec 21.

Abstract

BACKGROUND

Although the pepsinogen I/II (PGI/II) ratio after Helicobacter pylori eradication is recovered at short-term follow-up, long-term follow-up studies of PGI/II are rare.

METHODS

A total of 773 patients with gastric cancer who underwent endoscopic resection and pepsinogen and H. pylori tests were enrolled. H. pylori was eradicated in these patients. Endoscopic and pepsinogen tests were performed every year. A low PGI/II ratio was defined as ≤3.

RESULTS

The PGI/II ratio was higher in non-infected patients (n=275, 4.99) than infected patients (n=498, 3.53). After H. pylori eradication, the PGI/II ratio increased to 5.81 and 5.63 after 1 and 2 years (each p<0.05). The PGI/II ratio in the non-eradication group decreased to 3.94 and 2.75 after 1 and 2 years. The PGI/II ratio in the H. pylori eradication group became similar to that of the H. pylori-negative group at 3 (4.48 vs. 4.34), 4 (4.88 vs. 4.34), and 5 years (4.89 vs. 4.23). The adjusted odds ratios for a lower PG I/II ratio in the non-eradication group compared to the eradication group were 4.78 (95% CI 2.15-10.67) after 1year and 8.13 (95% CI 2.56-25.83) after 2 years.

CONCLUSIONS

After H. pylori eradication, the PGI/II ratio increased and was similar to that of H. pylori-negative controls for up to 5 years of follow-up.

摘要

背景

虽然幽门螺杆菌根除后胃蛋白酶原I/II(PGI/II)比值在短期随访中可恢复,但对PGI/II的长期随访研究较少。

方法

共纳入773例行内镜切除及胃蛋白酶原和幽门螺杆菌检测的胃癌患者。对这些患者进行幽门螺杆菌根除治疗。每年进行内镜和胃蛋白酶原检测。低PGI/II比值定义为≤3。

结果

未感染患者(n = 275,4.99)的PGI/II比值高于感染患者(n = 498,3.53)。幽门螺杆菌根除后,1年和2年后PGI/II比值分别升至5.81和5.63(均p<0.05)。未根除组的PGI/II比值在1年和2年后分别降至3.94和2.75。幽门螺杆菌根除组在3年(4.48对4.34)、4年(4.88对4.34)和5年(4.89对4.23)时的PGI/II比值与幽门螺杆菌阴性组相似。与根除组相比,未根除组PGI/II比值较低的校正比值比在1年后为4.78(95%CI 2.15 - 10.67),2年后为8.13(95%CI 2.56 - 25.83)。

结论

幽门螺杆菌根除后,PGI/II比值升高,在长达5年的随访中与幽门螺杆菌阴性对照相似。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验